Bone Health Care in Central London
Bone Health & Osteoporosis Screening at LSDC Healthcare provides a clinically structured, consultant-led evaluation of skeletal health during and after the menopause transition. Declining oestrogen levels accelerate bone loss, often silently.
Our service focuses on early detection, accurate risk stratification, and prevention of fragility fractures through evidence-based assessment.
Care is delivered in a private, unhurried environment in the City of London, with clear interpretation and integrated follow-up.
What Is Bone Health & Osteoporosis Screening?
This service is a comprehensive bone health assessment designed to identify osteopenia, osteoporosis, and fracture risk before clinical events occur.
It integrates:
Bone mineral density measurement
Biochemical assessment of bone metabolism
Clinical risk profiling
Menopause-specific risk evaluation
The goal is to move from reactive fracture care to preventative skeletal medicine.
Who Is This Screening For?
Bone health screening is recommended for women who:
Are peri- or postmenopausal
Have early or premature menopause
Have a family history of osteoporosis or fragility fractures
Have sustained a low-impact fracture
Use corticosteroids or aromatase inhibitors
Have low body weight, malabsorption, or thyroid disease
Are considering or using HRT and want bone risk assessment
Clinical Benefits and Indications
Clinical benefits include:
Early detection of reduced bone density
Accurate fracture risk assessment
Informed decisions around HRT and bone-protective therapy
Reduction in future fracture risk
Objective baseline for long-term monitoring
Common indications include:
Menopause transition
Prior fracture
High clinical risk profile
How LSDC Delivers This Differently
Bone health care at LSDC Healthcare is distinguished by:
Consultant-led interpretation of DEXA and biochemical data
Integration of menopause status into fracture risk analysis
Alignment with UK and international osteoporosis guidelines
Multidisciplinary input when required (endocrinology, nutrition)
Clear, actionable prevention and treatment plans
This is clinical bone health management, not isolated scanning.
Diagnostics and Investigations Involved
Assessment may include:
DEXA bone density scanning (hip and spine)
Vitamin D and calcium profiling
Thyroid and parathyroid assessment where indicated
Fracture risk estimation (e.g. FRAX® contextually applied)
Review of medications and lifestyle risk factors
Investigations are clinically selected and personalised.
Follow-Up and Ongoing Care
Results reviewed and explained by your consultant
Personalised bone protection strategy provided
Guidance on exercise, nutrition, and supplementation
Medical therapy initiated if indicated
Repeat monitoring scheduled where appropriate
Insurance and Self-Pay
Bone health and osteoporosis screening may be covered by UK private medical insurers when clinically indicated, subject to policy terms.
Self-pay options are available with transparent pricing.
LSDC Healthcare
A couple of minutes outside Liverpool St Station, this excellent facility is conveniently located for Medical consultations in London.
This facility is open during the evenings making it an excellent choice for busy professionals.
Book A Bone Health Assessment
If you are concerned about osteoporosis or want proactive skeletal health assessment during menopause, our consultants provide accurate evaluation and preventative guidance in Central London.
FAQ — Bone Health & Osteoporosis Screening
Does menopause increase osteoporosis risk?
Yes. Declining oestrogen accelerates bone loss, particularly in the first years after menopause.
Is a DEXA scan always required?
DEXA is recommended when fracture risk is significant or baseline measurement is clinically useful.
Can HRT protect bone health?
Yes. HRT can significantly reduce bone loss when appropriately prescribed.
What if my bone density is borderline?
Borderline results are managed with targeted prevention and monitoring.
Do supplements alone prevent osteoporosis?
Supplements support bone health but are not sufficient alone for high-risk patients.
Is screening covered by private insurance?
Coverage depends on clinical indication and insurer policy.